AIM ImmunoTech Inc Plunges 38.33% Amid Trading Halt

AIM ImmunoTech Inc (AIM) experienced a significant drop of 38.33% in pre-market trading on July 29, 2025, due to a trading halt triggered by volatility. This measure is typically implemented to ensure orderly trading during periods of substantial price movements, which can influence market behavior and future stock performance.

Analysts have set a one-year price target for AIM ImmunoTech Inc, with an average estimate of $150.00, indicating a potential upside of 910.10% from the current price. This optimistic outlook is supported by a consensus recommendation of "Outperform" from brokerage firms, suggesting a strong buy signal for the stock.

GuruFocus estimates the fair value of AIM ImmunoTech Inc to be $31.16 in one year, implying a 109.83% upside from the current price. This estimate is based on historical trading multiples, past business growth, and future performance projections, providing a comprehensive view of the stock's potential value.